Search
for
Sort by
Research 151–180 of 1000+
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- The Role of Tofacitinib in the Management of Alopecia Totalis
- 308 nm–Excimer light together with topical betamethasone valerate in treating alopecia areata
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Pharmacotherapy of alopecia areata
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Alopecia areata
- The role of lymphocytes in the development and treatment of alopecia areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Janus Kinase inhibitors in dermatology: a review
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Treatments for alopecia areata: a network meta-analysis
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- Topical cyclosporine in male pattern alopecia
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening